BioCentury
ARTICLE | Company News

Charles River, Genzyme Transgenics deal

February 12, 2001 8:00 AM UTC

CRL will acquire Primedica (Worcester, Mass.), a preclinical research group, from GZTC for $52 million, including $26 million in cash, $16.5 million in stock and $9.5 million in debt. CRL said the acq...